Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
about
Fixed-dose combination therapy for the prevention of cardiovascular diseaseRisk assessment in the prevention of cardiovascular disease in low-resource settingsMethodological Challenges in Estimating Trends and Burden of Cardiovascular Disease in Sub-Saharan AfricaRationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981)Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithmsStatus report on hypertension in Africa--consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD'sSafety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challengeAdenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentPlasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trialProtection against Plasmodium falciparum malaria by PfSPZ Vaccine.Risk screening for cardiovascular disease and diabetes in Latino migrant farmworkers: a role for the community health worker.Delivery of a small for gestational age infant and greater maternal risk of ischemic heart disease.Comparison of multiple obesity indices for cardiovascular disease risk classification in South Asian adults: The CARRS Study.Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study)Modeling the Burden of Cardiovascular Diseases in Iran from 2005 to 2025: The Impact of Demographic ChangesDegree of Agreement between Cardiovascular Risk Stratification Tools.Development and validation of a Score for Preoperative Prediction of Obstructive Sleep Apnea (SPOSA) and its perioperative outcomes.Physiological, Behavioral, and Dietary Characteristics Associated with Hypertension among Kenyan Defence Forces.High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.Growing epidemic of coronary heart disease in low- and middle-income countriesAssessing the performance of the Framingham Stroke Risk Score in the reasons for geographic and racial differences in stroke cohortA comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III populationEvaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers.The Framingham Heart Study's impact on global risk assessmentCardiovascular risk in Mozambique: who should be treated for hypertension?Using body mass index data in the electronic health record to calculate cardiovascular riskPrediction model for high glycated hemoglobin concentration among ethnic Chinese in Taiwan.Risk assessment and aspirin use in Asian and Western populations.A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trialComprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death.DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in AsiaCardiovascular risk scores do not account for the effect of treatment: a review.Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.Management of NCD in low- and middle-income countries.Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial.Training and supervision of community health workers conducting population-based, noninvasive screening for CVD in LMIC: implications for scaling up.Framingham ten-year general cardiovascular disease risk: agreement between BMI-based and cholesterol-based estimates in a South Asian convenience sample.Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
P2860
Q24198070-6381E4C9-F650-43E5-9717-2EB49B6362E4Q26744435-785297FA-E7C8-4680-92A7-6C2EBD623BBAQ26772252-E2B934BA-FADF-4341-BA81-4DF0CB1CC349Q26859060-A09D9C99-9CF2-4B3A-BD5D-8453E6621B4FQ26864118-E55125CE-0AFB-4FAD-9C2F-06F4C8A1C314Q26995763-20FA9003-B376-4F57-9120-1C61F2B4F06BQ28545017-DB79ED0F-E54B-40CE-9AD8-F41B6AAC1ACCQ28744136-7DCD7680-CFDB-43D5-B63B-D346BC9CF3A7Q28748765-0EFC2E80-8C4B-45CD-9A7A-AAE9CF9E2205Q30354426-6CEADE28-FC1F-4C0A-B301-66E4529EC801Q30458519-CAB70083-300E-4722-BD7F-0F12F2F66B8CQ31052158-E86D4048-9886-49B2-8717-E2D39BBDC215Q33610735-2DB60D1A-0CBA-4B5A-8D89-9E19D1FC14E4Q33613171-45E6CA37-D6F8-4FF8-B9C4-B7FE65BDA4EEQ33711082-7BEA0450-AA80-4268-BD46-964238690AFFQ33728818-A666D636-F18B-441F-947D-78A729DF4F09Q33743690-81867E0C-7E80-477E-AB28-8A1D3E8874B8Q33775326-10A310D8-02C7-478B-918D-3CEF99F3F9C3Q33828039-BD0336F2-4560-425D-8458-E48139A1616FQ33828135-9492B5E8-1773-401E-964C-27231B706BACQ33916879-5ACE48EB-FA0A-4C8B-BB53-8DA40C5C4AD8Q33927100-0504E9F9-519D-4F57-8114-12A27C46B4F4Q33940623-AD950C60-B65C-41A7-8587-0BF13A58AFE7Q33996738-60486FF5-697B-4411-BF08-E682F8D25491Q34182258-72AC423E-3D37-40AF-BED0-4FAD21D4DE57Q34198287-31840090-FAE9-4BBB-95DF-F28AFAC6E18CQ34203005-CCC448FF-4ECD-4C73-9EEF-93EEBA34D822Q34245212-04B3F74E-77FA-4199-9D18-F3D864666519Q34455516-0DA2C454-6C5E-4FDD-B0BE-28F0CFED59C8Q34460042-33F802B6-66BC-496D-8492-6CE171E9C967Q34606356-9AB6AE31-A3D1-4E58-8D56-CE621D2DA1D6Q34756253-3513E180-F4A1-40FD-829D-D09EDCD3D69DQ34769415-0A517A31-73BB-4462-88E2-6BC492A8D7ECQ34852105-520F344F-E701-4FBA-B09D-F8852E1CC39CQ34860519-8C3E6966-40C3-45EB-AA05-3B562C803785Q34987612-7A7FCF16-7743-466A-B690-1FC374AB937AQ35144775-3FC180C3-F2DC-4A06-BD2B-52DD00B9F5C0Q35166641-C98BC119-49B5-4DB5-9A72-8015A34CF14AQ35191286-C0494571-0182-45DB-B5E7-6A8E54188679Q35211679-0EFA9AF6-AFB9-4787-B349-3A34B9C6DF09
P2860
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@ast
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@en
type
label
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@ast
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@en
prefLabel
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@ast
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@en
P2093
P2860
P1433
P1476
Laboratory-based versus non-la ...... HANES I Follow-up Study cohort
@en
P2093
Cynthia R Young
Garrett Fitzmaurice
J Michael Gaziano
Thomas A Gaziano
P2860
P304
P356
10.1016/S0140-6736(08)60418-3
P407
P577
2008-03-01T00:00:00Z